ReviewComputational and structural biotechnology journal2026
Machine Learning in Stem Cell Research: From Biological Data to Clinical Translation.
Review in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Stem cell (SC) research plays a central role in disease modeling and regenerative medicine, yet its clinical translation remains challenged by biological heterogeneity, incomplete cellular maturation, stringent quality-control requirements, and increasingly complex biological and clinical data. Machine learning (ML) has emerged as a powerful computational approach for extracting biologically meaningful information from these data, enabling quantitative characterization of SC behavior and predictive modeling across diverse experimental and translational applications. This review presents a unified framework for ML in SC research by organizing the literature according to SC data sources and representations, ML methodologies and model families, and biological and clinical application domains. We review ML applications spanning SC reprogramming, differentiation, postdifferentiation maturation, quality control, disease modeling, therapeutic development, and clinical decision support, highlighting how diverse experimental data, including molecular and cellular profiling, biomedical imaging, biochemical profiling, functional measurements, and clinical data, enable biological interpretation, predictive modeling, and translational decision-making. We further discuss benchmark dataset selection, validation strategies, transformer-based foundation models, and emerging multimodal learning approaches and propose benchmark dataset selection criteria emphasizing biological diversity, experimental rigor, metadata completeness, reproducibility, and public accessibility. Collectively, this review provides a comprehensive framework for understanding current ML applications in SC research and outlines future directions toward robust, interpretable, and clinically translatable computational frameworks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.